<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2072-8174</journal-id>
<journal-title><![CDATA[Revista del Nacional (Itauguá)]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Nac. (Itauguá)]]></abbrev-journal-title>
<issn>2072-8174</issn>
<publisher>
<publisher-name><![CDATA[Hospital Nacional (Itauguá)]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2072-81742016000200004</article-id>
<article-id pub-id-type="doi">10.18004/rdn2016.0008.02.004-018</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Reacciones lepromatosas en pacientes adultos y pediátricos en un centro de referencia. Programa Nacional de Lepra, Paraguay]]></article-title>
<article-title xml:lang="en"><![CDATA[Lepromatous reactions in adults and pediatric outpatients in a reference center. National Lepra Program, Paraguay]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Samudio-Domínguez]]></surname>
<given-names><![CDATA[Gloria Celeste]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Espínola-Espínola]]></surname>
<given-names><![CDATA[Regina Beatriz]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Ministerio de Salud Pública y Bienestar Social Hospital Nacional Departamento de Pediatría]]></institution>
<addr-line><![CDATA[Itauguá ]]></addr-line>
<country>Paraguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Ministerio de Salud Pública y Bienestar Social Hospital General Barrio Obrero Servicio de Pediatría]]></institution>
<addr-line><![CDATA[Asunción ]]></addr-line>
<country>Paraguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2016</year>
</pub-date>
<volume>8</volume>
<numero>2</numero>
<fpage>4</fpage>
<lpage>18</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S2072-81742016000200004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_abstract&amp;pid=S2072-81742016000200004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_pdf&amp;pid=S2072-81742016000200004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción la lepra, llamada también enfermedad de Hansen, es una afección de la piel y de los nervios periféricos, infectocontagiosa, causada por Mycobacterium leprae. Las reacciones lepromatosas se presentan aún con tratamiento y son expresiones de respuesta inmunitaria. Conocerlas es importante a fin de facilitar el abordaje.  Objetivo determinar la frecuencia y tipo de reacciones lepromatosas en pacientes con diagnóstico de lepra que acuden al centro de referencia de Enfermedad de Hansen en el Hospital Distrital de San Lorenzo, de enero 2013 a diciembre 2015.  Metodología  observacional, descriptivo, retrospectivo de corte transverso.  Resultados  se incluyeron 217 pacientes, 72% presentaban lepra MB y 63% era de sexo masculino. La prevalencia de reacción lepromatosa fue 44%, siendo más frecuentes las de tipo 2 (65%). Se presentó reacción lepromatosa como debut de la enfermedad en 27 %. Treinta y tres pacientes presentaron de tres a doce episodios de reacción lepromatosa. El tratamiento fue talidomida y corticoides.  Conclusiones  la prevalencia de leprorreacciones fue cercana al 50%, predominando las de tipo 2. El tratamiento utilizado fue talidomida y/o corticoides dependiendo del tipo de reacción lepromatosa.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction  leprosy, wich is cause by Mycobacterium leprae, also known as Hansen's Disease, affects skin and peripheral nerves. Lepromatous reactions (LRs) are expressions of an immune reaction and remain as a major persistent problem. LRs are present even with appropriated treatment. Emphasis must be made in early diagnosis and prevention of the catastrophic consequences of LRs.  Objective  to determine the frequency and type of lepromatous reactions in leprosy patients with leprosy attending to reference center of Hansen´s Disease in the District Center Hospital in San Lorenzo, from January 2013 to December 2015.  Methodology  observational, retrospective cross sectional study.  Results  217 patients were included, 72% with multibacillary leprosy. 63% were male. Lepromatous reactions were found in 44%, been more frequent Type II reaction, in 65% of cases. LRs as oset disease occurred in 27%. 33 patients presented from 3 to 12 episodes of lepromatous reaction. The number of LRs episodes per patient were 3 to 12. Thalidomide was used as treatment in Erithema Nodosum Leprosum (ENL) and corticosteroids for the other types de LRs.  Conclusions  prevalence of PRs were 50%, been more frecuent the type II. Reaction the treatment used was Thalidomide and/or corticosteroids depending on the type of lepromatosus reaction.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Enfermedad de Hansen]]></kwd>
<kwd lng="es"><![CDATA[lepra]]></kwd>
<kwd lng="es"><![CDATA[estados lepromatosos reaccionales.]]></kwd>
<kwd lng="en"><![CDATA[Hansen's disease]]></kwd>
<kwd lng="en"><![CDATA[leprosy]]></kwd>
<kwd lng="en"><![CDATA[lepra reaction]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="">
<collab>Organización Panamericana de la Salud, Organización Mundial de la Salud</collab>
<source><![CDATA[Guía para la eliminación de la Lepra como problema de salud pública: la poliquimioterapia cura la lepra, detiene la transmisión y previene discapacidades]]></source>
<year>2000</year>
<page-range>38</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Diagnóstico y tratamiento de la lepra Instituto Nacional de Salud Pública, México]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[López-Antuñano]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
</person-group>
<source><![CDATA[S Publ Mex]]></source>
<year>1998</year>
<volume>40</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Situación de la lepra en el mundo]]></article-title>
<collab>Terencio de las Aguas J</collab>
<source><![CDATA[Med Cutan Iber Lat Am]]></source>
<year>2005</year>
<volume>33</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>191-2</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Lepra hoy: consideraciones epidemiológicas del Hospital Nacional]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aldama]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rivelli]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Aldama]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Ozecoski]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Gorostiaga]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev. Nac. (Itaugua)]]></source>
<year>2009</year>
<volume>1</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>27-30</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública y Bienestar Social. Dirección General de Atención Primaria de Salud</collab>
<source><![CDATA[Manejo del paciente de Lepra en Atención de la Primaria de la Salud: Protocolo 7]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Asunción ]]></publisher-loc>
<publisher-name><![CDATA[OPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Visita de Observación Conjunta al Programa Paraguayo de Control de Lepra]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Asunción ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Lepra: puesta al día. Definición, patogénesis, clasificación, diagnóstico y tratamiento]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eichelmann]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[González González]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Salas-Alanis]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Ocampo-Candiani]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Actas Dermosifil]]></source>
<year>2013</year>
<volume>104</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>554-63</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[La lepra (enfermedad de Hansen) CIE-9; CIE-10 a30 parte II: reacciones lepróticas y secuelas]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burstein]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev. Perú. med. exp. salud publica]]></source>
<year>2005</year>
<volume>22</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>151-3</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Detección extramuros de enfermedades de la piel]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Rivelli]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Guglielmone]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Aldama]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev. Nac. (Itauguá)]]></source>
<year>2011</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>48-51</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[La reacción leprosa una revisión]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reyes]]></surname>
<given-names><![CDATA[FO]]></given-names>
</name>
</person-group>
<source><![CDATA[Derm Venez]]></source>
<year>2000</year>
<volume>38</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>85-95</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Reacciones por Lepra en un Centro de referencia nacional en Colombia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nova]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sanchez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev. Biomed]]></source>
<year>2013</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>99-106</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Vigilancia de la lepra. Situación en el mundo y en España, 2010]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Bol Epidemiol Semanal]]></source>
<year>2009</year>
<volume>18</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>201-2</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Putinatti]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Lastória]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Padovani]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
</person-group>
<source><![CDATA[An Bras Dermatol]]></source>
<year>2014</year>
<volume>89</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>266-72</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Borderline lepromatous leprosy with type 1 (downgrading) reaction Clin Exp]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gohar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Dermatol]]></source>
<year>2014</year>
<volume>39</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>228</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Rare atypical presentations in Type 2 lepra reaction: a case series]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vijendran]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Verma]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Vasudevan]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Mitra]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Badad]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Neema]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Dermatol]]></source>
<year>2014</year>
<volume>53</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>323-6</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Lepra reaction with lucio phenomenon mimicking cutaneous vasculitis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Misra]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Parida]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Chowdhury]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Pani]]></surname>
<given-names><![CDATA[KC]]></given-names>
</name>
<name>
<surname><![CDATA[Kumari]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Krishnani]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[Case Reports Immunol]]></source>
<year>2014</year>
<volume>2014</volume>
<page-range>641989</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Lucio&amp;apos;sleprosy a clinical and therapeutic challenge]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jurado]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Novales]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Navarrete]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Dermatol]]></source>
<year>2015</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>66-78</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Lucio'sphenomenon: report of five cases]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Curi]]></surname>
<given-names><![CDATA[PF]]></given-names>
</name>
<name>
<surname><![CDATA[Villaroel]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Migliore]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Albertengo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Aquino]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Ceccato]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Rheumatol]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Voorend]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
<name>
<surname><![CDATA[Post]]></surname>
<given-names><![CDATA[EB]]></given-names>
</name>
</person-group>
<source><![CDATA[PLoS Negl Trop Dis]]></source>
<year>2013</year>
<volume>7</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>e2440</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="">
<collab>Ministerio de Salud Pública y Bienestar Social. Programa Nacional de Lepra</collab>
<source><![CDATA[Manual de normas y procedimientos: Programa Nacional de Control de Lepra Paraguay]]></source>
<year>2008</year>
</nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Retraso en el diagnóstico de lepra como factor pronóstico de discapacidad en una cohorte de pacientes en Colombia, 2000-2010]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guerrero]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Muvdi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[León]]></surname>
<given-names><![CDATA[CI]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Panam Salud Publica]]></source>
<year>2013</year>
<volume>33</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>137-43</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[epidemiology, progress, challenges and research gaps]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodrigues]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lokwood]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Leprosyn]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet Infect dis]]></source>
<year>2011</year>
<volume>11</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>464-70</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Leprosy update, 2011]]></article-title>
<collab>World Health Organization</collab>
<source><![CDATA[Weekly epidemiological record]]></source>
<year>2011</year>
<volume>36</volume>
<numero>86</numero>
<issue>86</issue>
<page-range>389-400</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Lepra clasificación y cuadro clínico]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torres Guerrero]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas Martínez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Atoche Diéguez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Arrazola]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Arenas Guzmán]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Dermatol Rev Mex]]></source>
<year>2012</year>
<volume>56</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>47-54</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Talidomida]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Menzinger]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Laffitte]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Dermatología]]></source>
<year>2015</year>
<volume>49</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nash]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[ILEP technical bulletin]]></source>
<year>2011</year>
<conf-name><![CDATA[ 18thMeeting of the ILEP Technical Commission]]></conf-name>
<conf-date>2011, October 11</conf-date>
<conf-loc>London </conf-loc>
</nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Multi-centre, double blind, randomized trial of three steroid regimens in the treatment of type-1 reactions in leprosy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sundar Rao]]></surname>
<given-names><![CDATA[PSS]]></given-names>
</name>
<name>
<surname><![CDATA[Sugamaran]]></surname>
<given-names><![CDATA[DST]]></given-names>
</name>
<name>
<surname><![CDATA[Richard]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[WCS]]></given-names>
</name>
</person-group>
<source><![CDATA[Leprosy Review]]></source>
<year>2006</year>
<volume>77</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>25-33</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The role of thalidomide in the management of erythema nodosum leprosum]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Waters]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lockwood]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Lepr Rev]]></source>
<year>2007</year>
<volume>78</volume>
<page-range>197-215</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Lepra dimorfa en estado reaccional tipo 1 y 2 = Multibacillary borderline leprosy with leprosy reaction type 1 and 2]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Montes]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Orozco]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Gaviria]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Asoc Col Dermatol]]></source>
<year>2009</year>
<volume>17</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>51-3</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ciertos aspectos inmunológicos en los estados reaccionales en la enfermedad de Hansen: revisión]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rada]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Aranzazu]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Convit]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Invest. clín]]></source>
<year>2005</year>
<volume>46</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>381-9</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Reacción en la lepra: presentación de un caso clínico]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moreira Ríos]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez Rivera]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz Rodríguez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera Moreira]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mujica González]]></surname>
<given-names><![CDATA[DB]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Ciencias Médicas]]></source>
<year>2012</year>
<volume>16</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>226-32</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Erythema multiforme in leprosy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Antunes]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Nery]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Sales]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sarno]]></surname>
<given-names><![CDATA[EN]]></given-names>
</name>
</person-group>
<source><![CDATA[Mem Inst Oswaldo Cruz]]></source>
<year>2012</year>
<volume>107</volume>
<numero>Suppl 1</numero>
<issue>Suppl 1</issue>
<page-range>34-42</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
